-- Retour --

Communications orales

Saturday 27 october 2018

1st Session : Antimicrobial Resistances

 

Algerian experience: Surveillance of antibiotic resistance in Algeria: challenges achievements and prospects.

H. TALI-MAAMAR

 

Extended Spectrum beta-lactamase producing Enterobacteriaceae in children at Mustapha Bacha University Hospital - Algiers.

H. ZIANE

Multiresistant Bacterial Infections: About 41 cases.

N. BOULAKEHAL

 

SYMPOSIUM MSD

 

2nd Seance

Invasive pneumococcal diseases in pre-vaccin in Algeria: circulating serotypes and antibiotic resistance.

H. ZIANE

 

Increased resistance to clarithromycin Helicobacterpylori in Algiers.

N. RAAF

 

Phenotypic and genotypic antibiotic-resistance in Campylobacter isolated from humans.

H. AMIR LAIDOUCI

Antibiotic resistance : Our role in emergence and intervention.

M. A. ALY

 

2nd Day : Sunday 28 october 2018

3rd Seance

Message of Michel SIDIBE Executive Director UNAIDS.HIV on MENA Region.

A.    ZEDDAM

 

The risk of HIV infection among health care workers: Results of 10 years of surveillance in an Algerian hospital.

B.    BEGHDADLI

 

Mother-to-child transmission prevention of HIV: A two years study.

A.    AIT ALI SLIMANE

B.     

Evaluation of primary and acquired resistance to HIV-1 in infected Algerian patients.

S. BOUZEGHOUB

 

 SYMPOSIUM BIOMERIEUX

 

4th Seance

Antiretrovirals and rapid weight gain in people living with HIV.

S. BESTAOUI

Place of HIV-AIDS in hospital mortality at Oran CHU in 2017.

N. HEROUAL

 

Sunday 28 october 2018 Afternoon

3rd Session: Viral Hepatitis

5th Séance

 

Initial assessment of patients with positive HCV serology

W. GUENIFI

 

Evaluation of the sofosbuvir-ledipasvir combination in patients infected with HCV genotype1

A.    TOUAREF

 

Efficacy and tolerability of Ledipasvir/Sofosbuvir on Chronic HCV Patients Attending Viral Hepatitis Clinic at Benghazi Medical Centre

A.    ELHASSI

 

Contribution to the eradication of Hepatitis C in dialysis patients in Mauritania by HCV testing and treatment with direct-acting antivirals

Z. FALL MALICK

 

HCV eradication therapy changing pattern of liver disease in Egypt

A. El RAY

 

 6th Seance

 

Viro-epidemiological situation of chronic viral hepatitis B and delta in northern Algeria

F. KHELIFA

 

The prognosis and managment of HBc Ag negative chronic infection

A.    LETAIEF

 

Prospective comparaison of transient elastographiy, fibrometer, APRI and FIB-4 with liver biopsy for the assessment of fibrosis in chronic hepatitis B

N. GUESSAB

 Liver fibrosis assessment by fibroscan and fibrometer in inactive hepatitis B carriers and selection for liver biopsy

O. DRIR

 

 Infection with the hepatitis delta virus (HDV) in Algeria and the Arab world

A. GASMI

 

 SYMPOSIUM SANOFI

 

3rd Day : Monday 29 october 2018

 4th Session : Emerging and Re -emerging Infections

 7th Seance

 

Inventory of the emerging and reemerging infectious diseases agents vectorized in Algeria

I. BITAM

 

Detection of relapsing fever Borrelia spp., Bartonella spp. And Anaplasmataceae bacteria in argasid ticks in Algeria

I.  LAFRI

 

Malaria in Tamanrasset 2012-2017

E. AKHAMOUK

 

Place and importance of isoenzymatic typing in the study of the epidemiology of the LCZ in a military environment in eastern Algeria

S. BENSEGHIER

 

 

8th Seance

 

 

Mobile laboratory and its contribution in the containment of emerging pathologies.

M. KELLY

 

 Algeria to the test of emerging diseases.

R. AIT HAMOUDA

12h00 - 12h15